Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04129411 · ClinicalTrials.gov registry record · NA
Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04129411: Completed NA study, sponsored by Mayo Clinic.
NCT04129411 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04129411, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Investigators intend to evaluate the efficiency of Radiofrequency ablation (RFA) therapy to treat papillary thyroid carcinoma.
Interventions
- DEVICE RFA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2020-06-15 |
| Est. Completion | 2024-05-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04129411
The ClinicalTrials.gov registry entry for NCT04129411 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RFA is the first listed.
NCT04129411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04129411 about?
NCT04129411 is a clinical study titled "Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation". Investigators intend to evaluate the efficiency of Radiofrequency ablation (RFA) therapy to treat papillary thyroid carcinoma.
What is the current status of trial NCT04129411?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2020-06-15. Estimated completion is 2024-05-07.
What interventions are being tested in trial NCT04129411?
The interventions under investigation include: RFA (DEVICE).
Who is sponsoring clinical trial NCT04129411?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.